NIDCD Names Dr. Andrew Griffith as Scientific Director
Dr. Andrew Griffith with researchers in his lab.
Andrew Griffith, M.D., Ph.D., chief of the Molecular Biology and Genetics Section and the Otolaryngology Branch at the NIDCD, has been appointed the institute’s new scientific director. Dr. Griffith succeeds Robert J. Wenthold, Ph.D., who will remain chief of the Section on Neurotransmitter Receptor Biology in the Laboratory of Neurochemistry.
“Dr. Griffith is an exceptional clinician and scientist who has made major advances in identifying genes associated with hereditary hearing loss,” said NIDCD director James F. Battey, Jr., M.D., Ph.D. “We’re fortunate to have someone with his experience at NIH continuing to build on the strong research foundation laid down by Dr. Wenthold.”
Dr. Griffith earned his M.D. and Ph.D. in molecular biophysics and biochemistry at Yale University, and went on to complete his residency in otolaryngology–head and neck surgery at the University of Michigan Medical School. He arrived at the NIDCD in 1998 as a research fellow with a clinical and basic scientific interest in hearing and balance, and became a tenure-track investigator in 2000. He was tenured and appointed chief of the Otolaryngology Branch in 2006. Among many other honors, Dr. Griffith has been awarded the M.D./Ph.D. Prize for Outstanding Graduate of the Medical Scientist Training Program at Yale in 1992, and the Presidential Early Career Award for Scientists and Engineers (PECASE) in 2002.
Dr. Griffith plans to continue the strong program of research in the mission areas of hearing, balance, smell, taste, voice, speech, and language already established at the NIDCD. He also hopes to build up the clinical research program and increase the diversity of investigators.
“Since I’m a clinician,” Dr. Griffith said, “I’m sensitive to the importance of trying to translate basic discoveries into things that benefit patients.”
Learn more about Dr. Griffith’s research.